TP53 and inflammatory bowel disease: Although we did not identify differences in expression of mutant p53 between a small cohort of IBD and sporadic colon cancers or an association between p53 status and miR-215 expression, these findings may provide insight into unique differences in mechanisms involving p53 in IBD and sporadic colon cancer [27].